Lombard Odier Asset Management (USA)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-102,294	Closed	-$283K	–	241
2016 Q2	$283K	Buy	102,294 +2,813	+3%	+$7.69K	0.03%	201
2016 Q1	$292K	Sell	99,481 -15,431	-13%	-$37.3K	0.04%	149
2015 Q4	$284K	Buy	114,912 +4,599	+4%	+$12.5K	0.03%	150
2015 Q3	$314K	Buy	110,313 +6,310	+6%	+$21.6K	0.03%	176
2015 Q2	$314K	Buy	104,003 +11,915	+13%	+$44.2K	0.02%	179
2015 Q1	$402K	Buy	+92,088	New	+$365K	0.03%	167

Other funds holding AUPH

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s AUPH Position: Q3 2016 in Review

Lombard Odier Asset Management (USA) sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2016, closing a stake of 102,294 shares — an estimated $283K sold.

Lombard Odier Asset Management (USA) first reported a position in AUPH in Q1 2015 and held it in 6 quarters. The position peaked at $402K in Q1 2015. 15 funds tracked by Wall St. Rank hold AUPH as of Q3 2016.

Lombard Odier Asset Management (USA) reported no remaining Aurinia Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 102,294 Aurinia Pharmaceuticals shares in Q3 2016, an estimated $283K.
Lombard Odier Asset Management (USA) first reported a position in Aurinia Pharmaceuticals in Q1 2015 and held it in 6 quarters.
Lombard Odier Asset Management (USA)'s Aurinia Pharmaceuticals position peaked at $402K in Q1 2015.
15 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2016.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2016, filed 15 Nov 2016.